Respiratory disease - Insights
Learn about our suite of tests that are designed to detect a variety of respiratory viruses, including COVID-19, influenza, and RSV.
Addiction rehabilitation monitoring - Insights
Encompassing comprehensive profiles, confirmatory testing, and interpretive results reporting, addiction rehabilitation monitoring at Mayo Clinic Laboratories supports patients affected by substance use disorder in their rehabilitation and...
Precision therapeutics - Insights
At Mayo Clinic Laboratories, utilization of precision therapeutics, or pharmacogenomic testing used in conjunction with therapeutic drug monitoring, provides personalized insights to guide and monitor prescription medication use.
Frequently asked questions - Insights
Check out how chromosomal microarray testing at Mayo Clinic Laboratories can help optimize treatment for neurological tumors.
A Test in Focus Archives - Page 9 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 8 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Find out more about our cost-effective immunoassay panel, which uses oral fluid testing to support addiction treatment and pain management.
Learn more about Mayo Clinic Laboratories’ testing to identify and monitor nicotine use as part of a patient’s nicotine-use cessation treatment plan, before anesthesia/surgery, or as part of insurance policy assessments.
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
See how our innovative evaluations detect multiple sclerosis with increased sensitivity to put patients on the correct diagnostic pathway.
Hereditary Alzheimer's disease and dementia - Insights
Learn about our genetic testing for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia, and CADASIL.
Pediatric CNS Disorder Testing - Mayo Clinic Laboratories
We offer a first-of-its-kind profile including only the antibodies that are pertinent to pediatric CNS disorders—all in one evaluation.
The following on demand education is related to the “Other” category in medical laboratory science (MLS), which encompasses a variety of specialized topics and emerging areas that don’t fall into traditional categories like hematology,...
Five Ways to Proactively Prepare for Laboratory's Unforeseen Situations - Insights
Unexpected events in the laboratory are an inevitability of the profession. The difference in whether it is manageable or chaotic comes down to the steps taken beforehand. By proactively preparing, you can drastically reduce the number of...
Nonradioactive assay helps diagnose heparin reaction - Insights
Rajiv Pruthi, M.B.B.S., explains how Mayo Clinic Laboratories’ serotonin release assay achieves high sensitivity and specificity while avoiding the use of radioactive materials. Serotonin release testing is an important tool in the...
GFAP: Novel Test for a Newly Identified Meningoencephalomyelitis - Insights
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis. Known as autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy, the condition was identified...
High-resolution targeted stimulant and phencyclidine (PCP) screen - Insights
In this month’s “Hot Topic,” Paul Jannetto, Ph.D., discusses the high-resolution targeted stimulant and PCP screening test from Mayo Clinic Laboratories, which offers sensitivity and specificity for use in the monitoring and management of...
hyperoxaluria_diagnostic_algorithm.pdf
10/2024© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Adapted from “The Primary Hyperoxalurias: An Algorithm for Diagnosis,” American Journal of Nephrology 2005;25:154-160. By permission S. Karger AG,...
High-Resolution Targeted Benzodiazepine Screen - Insights
In this “Hot Topic,” Paul Jannetto, Ph.D., highlights Mayo Clinic’s targeted benzodiazepine assay and discusses the advantages and limitations of various urine-screening assays as well as quantitative confirmatory testing to determine...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 24 - Insights
This week’s Research Roundup highlights the limitations of platform assays to measure serum 25OHD level impact on guidelines and practice decision-making.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 22 - Insights
This week’s Research Roundup highlights neoantigenic potential of complex chromosomal rearrangements in mesothelioma.
https://news.mayocliniclabs.com/file-activity-metrics-qrg/
Activity Metrics Quick Reference Guide 800-533-1710 mayocliniclabs.com Effective Date: 9/26/2024 Log in to Activity Metrics 1. On MayoClinicLabs.com, at top right, click My Dashboard. 2. Enter your Professional username (email...
August 2021 - Clinical Microbiology and Infectious Disease Pathology - Insights
This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.
April 2023 - Gynecological Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gynecological Pathology.
Browse our menu of immunoglobulin E (IgE) antibody testing, which can be useful in the evaluation of patients suspected of having an allergic disease.
Perspectives Archives - Page 3 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Perspectives Archives - Page 4 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Laboratory Space Design: The Next Frontier - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, is kicking off a blog series that will discuss a methodology that can be used in the design of a new laboratory space or the redesign of an existing laboratory space.
Perspectives Archives - Page 2 of 9 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 18 - Insights
This week’s Research Roundup highlights Mayo Clinic researchers who conducted a study to characterize the clinical, pathologic, and survival implications of non-V600 BRAF mutations in metastatic colorectal cancer.
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 16 - Insights
This week’s Research Roundup highlights the role of deficient DNA mismatch repair status in patients with stage III colon cancer treated with FOLFOX adjuvant chemotherapy.
Research Archives - Page 33 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
Research Roundup Archives - Page 4 of 29 - Insights
Skip to Content MayoACCESS MayoLINK...
People Archives - Page 35 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
December 2023 - Gynecological Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Gynecological Pathology.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Leveraging the Laboratory: Seize Tomorrow - Insights
Mayo Clinic Laboratories’ Outreach Conference will be held Sept. 17–18, 2024, in Rochester, Minnesota. “Leveraging the Laboratory: Seize Tomorrow” will provide innovative views into all aspects of health system laboratory outreach programs.
Mayo Clinic Laboratory and Pathology Research Roundup: June 25 - Insights
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
Research Archives - Page 4 of 33 - Insights
Skip to Content MayoACCESS MayoLINK...
September 2023 - Cardiovascular Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.
Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 - Insights
This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4 - Insights
This week’s Research Roundup highlights individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.
Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 - Insights
This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.
Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer - Insights
Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.